- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/44 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere
Patent holdings for IPC class C07K 16/44
Total number of patents in this class: 1844
10-year publication summary
|
132
|
133
|
131
|
132
|
142
|
123
|
118
|
112
|
130
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Yale University | 2461 |
60 |
| Hoffmann-La Roche Inc. | 3602 |
38 |
| Siwa Corporation | 59 |
38 |
| Janssen Pharmaceutica N.V. | 3340 |
34 |
| F. Hoffmann-La Roche AG | 7893 |
33 |
| The Regents of the University of California | 20355 |
28 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
28 |
| ARK Diagnostics, Inc. | 34 |
25 |
| Jiangnan University | 1572 |
22 |
| Northern Bank Limited | 69 |
22 |
| MacroGenics, Inc. | 233 |
19 |
| Siemens Healthcare Diagnostics Inc. | 2126 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
16 |
| Genentech, Inc. | 4040 |
15 |
| Board of Regents, The University of Texas System | 5989 |
14 |
| Academia Sinica | 955 |
14 |
| Amgen Inc. | 4290 |
13 |
| President and Fellows of Harvard College | 6049 |
13 |
| IBC Pharmaceuticals, Inc. | 90 |
13 |
| IDEXX Laboratories, Inc. | 872 |
13 |
| Other owners | 1368 |